Published in Cancer Weekly, October 17th, 2006
"Based on its mechanistic similarity to fludarabine and cladribine and the success of these analogues for treatment of CLL, we hypothesized that clofarabine would be effective for indolent leukemias. The present study was conducted to determine the efficacy and cellular pharmacology during clinical trials of single-agent clofarabine in CLL," scientists in the United States reported.
"Previously treated patients with relapsed/refractory CLL...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.